Cargando…
Recent Developments in Nanomedicine for Pediatric Cancer
Cancer is the second biggest cause of death in children in the US. With the development of chemotherapy, there has been a substantial increase in the overall survival rate in the last 30 years. However, the overall mortality rate in children with cancer remains 25%, and many survivors experience a d...
Autores principales: | Yang, Shicheng, Wallach, Mia, Krishna, Apurva, Kurmasheva, Raushan, Sridhar, Srinivas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036287/ https://www.ncbi.nlm.nih.gov/pubmed/33916177 http://dx.doi.org/10.3390/jcm10071437 |
Ejemplares similares
-
Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy
por: Singh, Bijay, et al.
Publicado: (2020) -
Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing
por: Ghilu, Samson, et al.
Publicado: (2021) -
Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma
por: Baldwin, Paige, et al.
Publicado: (2019) -
Recent Development of pH-Responsive Polymers for Cancer Nanomedicine
por: Tang, Houliang, et al.
Publicado: (2018) -
A Recent Review on Cancer Nanomedicine
por: Giri, Paras Mani, et al.
Publicado: (2023)